EPS Creative Health Technology Group Limited (HK:3860) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EPS Creative Health Technology Group Limited anticipates a significant reduction in its annual loss to approximately HKD 30 million for the financial year ended March 31, 2024, improving from a HKD 50 million loss the previous year. This positive shift is primarily due to increased revenue from the company’s healthcare products business. Investors are advised to be cautious as these are preliminary results and the final audited financials will be released by the end of June 2024.
For further insights into HK:3860 stock, check out TipRanks’ Stock Analysis page.